ILYANG PHARMACEUTICAL CO.,LTD Logo

ILYANG PHARMACEUTICAL CO.,LTD

Develops and manufactures a diverse range of pharmaceuticals and consumer health products.

007570 | KO

Overview

Corporate Details

ISIN(s):
KR7007570005
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 하갈로 110, 용인시

Description

Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
회계처리기준위반에따른검찰고발등조치
Korean 7.0 KB
2025-09-11 00:00
기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 4.9 KB
2025-09-11 00:00
[기재정정]기타시장안내 (상장적격성 실질심사 사유 발생)
Korean 8.2 KB
2025-09-10 00:00
매매거래정지및정지해제(풍문등조회공시)
Korean 5.1 KB
2025-09-10 00:00
조회공시요구(풍문또는보도)
Korean 3.5 KB
2025-09-05 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 13.1 KB
2025-08-18 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 27.7 KB
2025-08-18 00:00
신탁계약해지결과보고서
Korean 19.8 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.6 MB
2025-06-02 00:00
단일판매ㆍ공급계약체결
Korean 7.5 KB
2025-05-21 00:00
신탁계약에의한취득상황보고서
Korean 55.7 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-05-13 00:00
최대주주등소유주식변동신고서
Korean 32.6 KB
2025-04-30 00:00
최대주주등소유주식변동신고서
Korean 37.6 KB

Automate Your Workflow. Get a real-time feed of all ILYANG PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILYANG PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILYANG PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.